Posts by Sandra Ansanay-Alex
SIB inaugurates its Centre for Pathogen Bioinformatics
SIB has launched a new Centre for Pathogen Bioinformatics, building on its contributions during the COVID-19 pandemic. The Centre will offer expertise and services in computational pathogen research and surveillance to Swiss federal authorities and the global research community. The Centre for Pathogen Bioinformatics’s goal is to ensure Switzerland remains a leader in…
Read MoreActival Revolutionizes Dental Aligners with Innovative Microchannel Technology
Actival, a Neuchâtel-based startup supported by the CSEM (Swiss Center for Electronics and Microtechnology), is transforming the dental aligner market with its innovative “Active Aligners”. They incorporate patented 3D-printed microchannel technology, ensuring optimal oral hygiene throughout the treatment period. Microchannels for Better Hygiene Traditional aligners, while discreet and comfortable, have been linked to…
Read MoreSeprify SA & Xemperia, finalists of the IFF Prize
The State of Fribourg and BCF announce the nine finalists for the IFF Prize. 9 companies, out of 39 applications, have been selected. Two of them, Xemperia and Seprify, are promising start-ups of the Swiss Health Valley. Seprify SA: A white pigment derived from cellulose Seprify develops and produces plant-based ingredients to offer…
Read MoreFDA Clears Abionic’s IVD CAPSULE PSP for Early Detection of Sepsis
Abionic, a Vaud-based medical diagnostics company, announced that its IVD CAPSULE PSP test received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This test, designed for the early detection of sepsis, represents a major breakthrough in sepsis diagnostics by significantly reducing the time-to-detection, potentially improving patient outcomes. The FDA clearance marks an important…
Read MoreThe CHUV launches the Swiss BioMotion Lab
This laboratory, which specialises in the analysis and rehabilitation of movement, will enable large-scale research to be carried out and patients, particularly those suffering from osteoarthritis, to benefit from biomechanical data that until now has been used mainly in research. Osteoarthritis is the most common joint disease, marked by the progressive breakdown of…
Read MorePerivision raises CHF 1.1 Million
PeriVision, Inselspital and the University of Bern receive a CHF 1.1 Million grant to build new functional eye tests in retinal diseases like age-related macular degeneration (AMD), geographic atrophy (GA) or diabetic retinopathy (DR) which affect hundreds of millions worldwide. Normally, patients with AMD, GA or DR struggle with standard eye tests such as…
Read MoreA breakthrough in the fight against brain cancer
Researchers at HUG and UNIGE have succeeded in generating cells that kill diseased cells. It works on mouse glioblastoma. Glioblastoma is the most common and most aggressive brain tumour. Current treatments are not very effective: average survival after diagnosis is less than two years. But science is making progress. A team from the University…
Read MoreIntuitive Expands in the Canton of Vaud
Intuitive, a pioneer of robotic-assisted surgery, has expanded its European headquarters in Aubonne, now employing over 250 people. Founded in 1995 in California (USA), Intuitive is the manufacturer of the da Vinci surgical system, a minimally invasive robotic-assisted surgical platform, which has been used by skilled surgeons worldwide for more than two decades.…
Read MoreGenolier Innovation Hub – A Pioneer in Medical Innovation
The Genolier Innovation Hub was inaugurated this Friday 27 September in canton of Vaud. With a CHF 100 million investment, the site aims at fostering innovation in healthcare in the Swiss Health Valley and internationally. Positioned next to the Genolier clinic, the 25,000 square-meter building is designed to encourage interdisciplinary collaboration between research, industry,…
Read Moreten23 health Opens State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp
This advanced, energy-efficient plant will enhance the company’s capabilities in commercial and clinical manufacturing of sterile medicines, including vials, syringes, and cartridges. The Swiss CDMO celebrates the grand opening of its VIVA2® facility in Visp. The facility adds two production lines: Line 2, designed for large-scale filling of ready-to-use containers, and Line 3,…
Read More